The global fatty liver treatment market, valued at approximately USD 20 Billion in 2022, is anticipated to witness ...

In the inaugural episode of "Unlocking the Fatty Liver Mistry," Dr. Neeraj Mistry, Chief Medical Officer of the Fatty Liver Foundation, shares crucial insights on the often-overlooked health ...

Mr McHugh said he was puzzled to receive a letter out of the blue as he had "no symptoms". Two weeks later, Mr McHugh had an ...

Non-alcoholic fatty liver disease (NAFLD) is the physiological manifestation of obesity in the liver. The prevalence of NAFLD has increased from 25.24% in 2015 to 29.38% in 2021, and this condition ...

While the treatment options for this aggressive ... Cavefish Provide New Insight Into Fatty Liver Disease Mar. 18, 2024 — Fatty liver, which can lead to liver damage and disease, can occur ...

Learn about HMGB1's crucial role in liver diseases, its pathways and therapeutic potential that can treat liver diseases.

The risk increases significantly for individuals who carry these viruses long-term without treatment. While Hepatitis B has a ...

More than a third (38%) of adults globally have MASLD, which is expected to increase to more than 55% by 2040. 2 There are ...

Shockingly, there has been an almost 47 percent increase in hospital admissions due to this disease in England in just 10 ...

UAB researchers have reversed metabolic dysfunction-associated steatohepatitis (MASH) in mouse models. MASH is a severe liver disease associated with obesity and type 2 diabetes that affects more than ...

Obesity, alcohol use and other factors are driving up rates of fatty liver disease among American adults, new research warns. By 2018, federal data showed that 42% of adults had some form of fatty ...